MAPT and Alzheimer disease: In this study, we extend previous published findings from our lab and others that show DYRK1A is involved in phosphorylation of tau protein on sites that are hyperphosphorylated during the course of tau pathology in AD and show that certain β-carboline alkaloids can significantly reduce the levels of phosphorylated tau protein.